The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT(*D)
Last

(U.S.) $0.90

Today's change0.00 0.00%
Updated August 17 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT(*D)
Last

(U.S.) $0.90

Today's change0.00 0.00%
Updated August 17 3:59 PM -4GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc closed at (U.S.)$0.90.

Over the last five days, shares have gained 8.12%, but are down 7.41% for the last year to date. Shares have underperformed the S&P 500 by 19.70% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $0.90
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-7.41%
  • Volume0
  • Average volume (10-day)333,577
  • Average volume (1-month)201,298
  • Average volume (3-month)149,098
  • 52-week range(U.S.) $0.70 to (U.S.) $1.53
  • Beta0.53
  • Trailing P/E11.51×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.09
Updated August 17 3:59 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.88%

Based on its net profit margin of 1.88%, Neptune Technologies & Bioressources Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.32%Sector:Industry:

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Nov 30, 201611/30/2016Aug 31, 201608/31/2016May 31, 201605/31/2016
Revenue12121211
Total other revenue--------
Total revenue12121211
Gross profit3334
Total cost of revenue9998
Total operating expense1121414
Selling / general / administrative5534
Research & development--112
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-2-130--
Operating income110-2-2
Interest income (expense), net non-operating-----1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax09-2-4
Income after tax-29-2-4
Income tax, total2000
Net income011-1-2
Total adjustments to net income--------
Net income before extra. items011-1-2
Minority interest2112
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items011-1-2
Inc. avail. to common incl. extra. items011-1-2
Diluted net income011-1-2
Dilution adjustment--------
Diluted weighted average shares78787878
Diluted EPS excluding extraordinary itemsvalue per share-0.010.14-0.02-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.010.14-0.02-0.03